MedTrace Logo

Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients

NCT03484741 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-04-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) transplantation for type 1 Diabetes Mellitus patients.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL

MSC and PRP

MSC are collected from autologous bone marrow mononuclear cells (BMNC) and allogeneic umbilical cord tissue (UC-MSC) under sterile conditions and combined with activated platelet-rich plasma (PRP) to treat this disease.

Sponsors & Collaborators

  • University of Science Ho Chi Minh City

    collaborator OTHER

  • Van Hanh General Hospital

    lead OTHER

Principal Investigators

  • Phuong Le, MSc-MD · Stem Cell Unit, Van Hanh General Hospital

  • Ngoc Phan, MSc · Stem Cell Institute, University of Science Ho Chi Minh City

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484741 on ClinicalTrials.gov